Education
About Us
Working with TipRanks
Follow Us
Protagonist Therapeutics Inc (DE:PGF)
:PGF
RESEARCH TOOLSreports
PGF Analyst Ratings
Strong Buy
9 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
PGF Stock 12 Month Forecast
Average Price Target
€60.33
▲(50.08% Upside)
| Highest Price Target€72.97 | Average Price Target€60.33 | Lowest Price Target€33.82 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Best Analysts Covering Protagonist Therapeutics
Which Analyst Should I Follow If I Want to Buy DE:PGF and Sell After:
1 Month
xxx
Success Rate
10/13 ratings generated profit
Average Return
+11.68%
assigned a xxx
rating 10 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 76.92% of your transactions generating a profit, with an average return of +11.68% per trade.
3 Months
xxx
Success Rate
10/13 ratings generated profit
Average Return
+17.17%
assigned a xxx
rating 10 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 76.92% of your transactions generating a profit, with an average return of +17.17% per trade.
1 Year
Success Rate
21/21 ratings generated profit
Average Return
+71.94%
reiterated a buy rating 2 months ago
Copying Jonathan Wolleben's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +71.94% per trade.
2 Years
xxx
Success Rate
21/21 ratings generated profit
Average Return
+132.79%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +132.79% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
PGF Analyst Recommendation Trends
Rating
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Strong Buy
4
8
13
16
13
Buy
17
15
19
19
11
Hold
2
2
1
1
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
23
25
33
36
24
Each month's total comprises the sum of three months' worth of ratings.
PGF Financial Forecast
PGF Stock Forecast FAQ
What is DE:PGF’s average 12-month price target, according to analysts?
Based on analyst ratings, Protagonist Therapeutics Inc’s 12-month average price target is 60.33.
What is DE:PGF’s upside potential, based on the analysts’ average price target?
Protagonist Therapeutics Inc has 50.08% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Protagonist Therapeutics Inc a Buy, Sell or Hold?
Protagonist Therapeutics Inc has a consensus rating of Strong Buy, which is based on 9 buy ratings, 1 hold ratings and 0 sell ratings.
What is Protagonist Therapeutics Inc’s share price target?
The average share price target for Protagonist Therapeutics Inc is 60.33. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €72.97 ,and the lowest forecast is €33.82. The average share price target represents 50.08% Increase from the current price of €40.2.
The highest analyst share price target is €72.97 ,and the lowest forecast is €33.82. The average share price target represents 50.08% Increase from the current price of €40.2.
What do analysts say about Protagonist Therapeutics Inc?
Protagonist Therapeutics Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Streets Analysts.
How can I buy shares of Protagonist Therapeutics Inc?
To buy shares of DE:PGF, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.